Last reviewed · How we verify

NCT07369206

ICU Admission Diagnoses and ICU Mortality

Completed Last updated 4 February 2026
What this trial tests

trial in Critical Illness in 1,248 participants. Completed in 2 February 2026.

Timeline
30 January 2026
Primary endpoint
2 February 2026
2 February 2026

Quick facts

Lead sponsorAtaturk University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,248
Start date30 January 2026
Primary completion2 February 2026
Estimated completion2 February 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Ataturk University

Who can join

18 and older, any sex, with Critical Illness or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective cohort study will evaluate whether syndromic clinical diagnoses present at ICU admission are associated with ICU mortality, independent of physiologic severity scores. Adult patients admitted to a tertiary mixed ICU during 2025 will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07369206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing